Krebs Biochemicals and Industries share news, announcements and annual reports
NSE: KREBSBIOBSE: 524518Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹57.93.
30 Oct: open ₹56.60, high ₹58.49, low ₹56.33
- Under NSE's long-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹122 Cr2,740th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −14.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- Net worth zero or below
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 5,39760.1% delivered
Krebs Biochemicals and Industries has 498 announcements on record, routine notices left out; 2 in the 30 days to 30 Oct 2026, the latest on 29 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Krebs Biochemicals and Industries quarterly results
The board met on 29 Oct 2026 to consider financial results and other business matters
Notice filed 16 Oct 2026
Krebs Biochemicals and Industries annual reports, presentations and earnings calls
The company's own documents, latest first.Krebs Biochemicals and Industries financials, year by year
Annual reports14
- Annual report, year to Mar 20264 Sep 2026
- Annual report, year to Mar 202528 Aug 2025
- Annual report, year to Mar 20242 Sep 2024
- Annual report, year to Mar 20234 Sep 2023, a zip file
- Annual report, year to Mar 20226 Sep 2022, a zip file
9 earlier reports
- Annual report, year to Mar 20202 Sep 2020, a zip file
- Annual report, year to Mar 201931 Aug 2019, a zip file
- Annual report, year to Mar 20184 Oct 2018, a zip file
- Annual report, year to Mar 20175 Oct 2017, a zip file
- Annual report, year to Mar 20163 Oct 2016, a zip file
- Annual report, year to Mar 20154 Sep 2015, a zip file
- Annual report, year to Mar 201218 Sep 2012, a zip file
- Annual report, year to Mar 201120 Sep 2011, a zip file
- Annual report, year to Mar 201019 Apr 2011, a zip file
Krebs Biochemicals and Industries share news and announcements
Newest first. Page 1 of 10.
Oct 2026
29 Oct · Results
Sep 2026
29 Sep · Meeting
Aug 2026
6 Aug · Results
Jul 2026
Jun 2026
26 Jun · Board meeting
May 2026
21 May · Results
Apr 2026
10 Apr · Legal
The exchange asked on 8 Apr 2026
Feb 2026
9 Feb · Results
Jan 2026
Dec 2025
Nov 2025
18 Nov · Updates
4 Nov · Results
4 Nov · Board meeting
Oct 2025
8 Oct · Updates
Sep 2025
26 Sep · Meeting
Aug 2025
7 Aug · Updates
7 Aug · Results
Jul 2025
Jun 2025
May 2025
20 May · Results
20 May · Board meeting
Apr 2025
Mar 2025
31 Mar · Meeting
Feb 2025
24 Feb · Meeting
10 Feb · Updates
4 Feb · Updates
4 Feb · Management
4 Feb · Results
4 Feb · Board meeting
Jan 2025
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 29 Oct 2026Resultsdown 2.06%−3.0 pts vs Nifty 500market median −0.7% · volume 0.1× usual · delivery +16.4 pts against usual · The announcement
- 6 Aug 2026Resultsup 0.72%+0.7 pts vs Nifty 500market median −0.7% · five sessions +1.2% (+1.5 pts vs Nifty 500) · volume 0.4× usual · delivery +15.9 pts against usual · The announcement
- 21 May 2026Resultsup 1.65%+1.5 pts vs Nifty 500market median −0.7% · five sessions +23.5% (+21.8 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 4 Nov 2025Resultsup 0.29%+0.9 pts vs Nifty 500market median −0.7% · five sessions −2.2% (−1.6 pts vs Nifty 500) · volume 0.2× usual · delivery −19.5 pts against usual · The announcement
- 7 Aug 2025Resultsup 0.42%+0.3 pts vs Nifty 500market median −0.7% · five sessions −1.4% (−1.6 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 28 Jul 2025Board or managers changeddown 3.97%−3.2 pts vs Nifty 500market median 0.0% · five sessions −3.7% (−2.3 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 21 May 2025Resultsdown 1.14%−1.8 pts vs Nifty 500market median −0.7% · five sessions −1.5% (−2.5 pts vs Nifty 500) · volume 1.7× usual · delivery −6.0 pts against usual · The announcement
- 24 Mar 2025Board or managers changeddown 1.84%−3.1 pts vs Nifty 500market median 0.0% · five sessions −12.7% (−13.0 pts vs Nifty 500) · volume 0.8× usual · The announcement
- 10 Mar 2025Board or managers changeddown 5.00%−4.1 pts vs Nifty 500market median 0.0% · five sessions −12.2% (−11.4 pts vs Nifty 500) · volume 1.8× usual · The announcement
- 12 Feb 2025Board or managers changeddown 4.11%−3.9 pts vs Nifty 500market median 0.0% · five sessions −9.9% (−8.3 pts vs Nifty 500) · volume 0.3× usual · The announcement
20 earlier announcements
- 4 Feb 2025Resultsup 4.58%+3.1 pts vs Nifty 500market median −0.7% · five sessions +0.1% (+0.3 pts vs Nifty 500) · volume 7.4× usual · The announcement
- 31 Dec 2024Board or managers changedup 1.44%+1.4 pts vs Nifty 500market median 0.0% · five sessions +3.6% (+4.2 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 11 Nov 2024Resultsdown 4.84%−4.6 pts vs Nifty 500market median −0.7% · five sessions −10.6% (−7.3 pts vs Nifty 500) · volume 13.7× usual · The announcement
- 7 Aug 2024Resultsdown 2.10%−3.9 pts vs Nifty 500market median −0.7% · five sessions −4.9% (−6.1 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 15 Apr 2024Board or managers changeddown 3.92%−2.6 pts vs Nifty 500market median 0.0% · five sessions +0.7% (+1.5 pts vs Nifty 500) · volume 1.0× usual · delivery −25.9 pts against usual · The announcement
- 12 Feb 2024Resultsdown 0.68%+0.8 pts vs Nifty 500market median −0.7% · five sessions +0.3% (−0.7 pts vs Nifty 500) · volume 0.3× usual · delivery −3.3 pts against usual · The announcement
- 8 Nov 2023Resultsdown 1.64%−2.1 pts vs Nifty 500market median −0.7% · five sessions −8.0% (−8.8 pts vs Nifty 500) · volume 0.8× usual · delivery +0.7 pts against usual · The announcement
- 23 Oct 2023Board or managers changeddown 5.01%−3.2 pts vs Nifty 500market median 0.0% · five sessions −6.9% (−4.7 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 10 Aug 2023Resultsdown 3.51%−3.1 pts vs Nifty 500market median −0.7% · five sessions +4.4% (+5.6 pts vs Nifty 500) · volume 1.3× usual · The announcement
- 25 May 2023Resultsdown 3.61%−3.9 pts vs Nifty 500market median −0.7% · five sessions −0.9% (−2.5 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 6 Feb 2023Resultsup 1.26%+1.4 pts vs Nifty 500market median −0.7% · five sessions −1.4% (−1.8 pts vs Nifty 500) · volume 7.4× usual · delivery +27.4 pts against usual · The announcement
- 6 Feb 2023Board or managers changedup 1.26%+1.4 pts vs Nifty 500market median 0.0% · five sessions −1.4% (−1.8 pts vs Nifty 500) · volume 7.4× usual · delivery +27.4 pts against usual · The announcement
- 2 Aug 2022Resultsdown 4.34%−4.5 pts vs Nifty 500market median −0.7% · five sessions −4.3% (−5.3 pts vs Nifty 500) · volume 0.6× usual · delivery −9.8 pts against usual · The announcement
- 23 May 2022Resultsdown 5.29%−4.9 pts vs Nifty 500market median −0.7% · five sessions −9.8% (−9.7 pts vs Nifty 500) · volume 1.4× usual · delivery +6.5 pts against usual · The announcement
- 9 Nov 2021Board or managers changeddown 1.36%−1.5 pts vs Nifty 500market median 0.0% · five sessions −3.0% (−3.5 pts vs Nifty 500) · volume 1.9× usual · delivery −25.7 pts against usual · The announcement
- 2 Aug 2021Resultsdown 0.88%−1.8 pts vs Nifty 500market median −0.7% · five sessions −2.6% (−4.8 pts vs Nifty 500) · volume 1.7× usual · delivery −1.6 pts against usual · The announcement
- 27 May 2021Resultsdown 9.85%−10.2 pts vs Nifty 500market median −0.7% · five sessions −10.5% (−12.4 pts vs Nifty 500) · volume 2.9× usual · delivery −11.6 pts against usual · The announcement
- 1 Feb 2021Resultsdown 5.88%−10.0 pts vs Nifty 500market median −0.7% · five sessions −5.4% (−14.0 pts vs Nifty 500) · volume 1.0× usual · delivery +7.5 pts against usual · The announcement
- 6 Nov 2020Resultsdown 2.32%−3.3 pts vs Nifty 500market median −0.7% · five sessions −4.0% (−8.1 pts vs Nifty 500) · volume 0.5× usual · delivery +8.1 pts against usual · The announcement
- 10 Aug 2020Resultsdown 2.18%−2.9 pts vs Nifty 500market median −0.7% · five sessions −8.2% (−8.4 pts vs Nifty 500) · volume 0.8× usual · delivery −4.3 pts against usual · The announcement
Krebs Biochemicals and Industries results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Revenue from operations | Quarter to Jun 2022 | Standalone | 9.92 | 10.64 | +7.2% | 4 Aug 2022 | 23 Nov 2022 |
| Other income | Quarter to Jun 2022 | Standalone | 0.85 | 0.13 | −84.7% | 4 Aug 2022 | 23 Nov 2022 |
| Total income | Quarter to Jun 2022 | Standalone | 10.77 | 10.77 | 0.0% | 4 Aug 2022 | 23 Nov 2022 |
| Employee costs | Quarter to Jun 2022 | Standalone | 3.66 | 3.66 | 0.0% | 4 Aug 2022 | 23 Nov 2022 |
| Other expenses | Quarter to Jun 2022 | Standalone | 5.73 | 5.73 | 0.0% | 4 Aug 2022 | 23 Nov 2022 |
| Profit before tax | Quarter to Jun 2022 | Standalone | −8.14 | −8.14 | 0.0% | 4 Aug 2022 | 23 Nov 2022 |
| Net profit | Quarter to Jun 2022 | Standalone | −8.14 | −8.14 | 0.0% | 4 Aug 2022 | 23 Nov 2022 |
| Profit before one-off items and tax | Quarter to Jun 2022 | Standalone | −8.14 | −8.14 | 0.0% | 4 Aug 2022 | 23 Nov 2022 |
| Net profit from continuing businesses | Quarter to Jun 2022 | Standalone | −8.14 | −8.14 | 0.0% | 4 Aug 2022 | 23 Nov 2022 |
| Total comprehensive income | Quarter to Jun 2022 | Standalone | −8.14 | −8.14 | 0.0% | 4 Aug 2022 | 23 Nov 2022 |